More
    NewsEuropeEuropean Union authorizes new vaccine production sites

    European Union authorizes new vaccine production sites

    The European Union’s pharmaceutical regulator said Friday that it approved manufacturing sites for coronavirus vaccines made by Pfizer-BioNTech, Moderna and AstraZeneca, a move that will significantly increase the supply of the vaccines in Europe and speed up vaccination efforts on the continent.

    The European Medicines Agency said in a statement that it had approved sites in the Netherlands, Germany and Switzerland for COVID-19 vaccines manufactured by the drugmakers.

    Read also: Former U.S. CDC director claims coronavirus originated in Wuhan lab

    The 27-nation bloc is fighting to speed up COVID-19 vaccination, and repeated distribution delays and manufacturing problems.

    Read Also:   Spain Coronavirus Live Updates

    The agency said it approved a plant in Leiden, the Netherlands, to manufacture the active ingredient in AstraZeneca’s vaccine, for a total of four licensed sites.

    The EU regulator said it also gave the green light to a site in Marburg, Germany, to make both the active substance and the full vaccine developed by BioNTech and Pfizer.

    It added that it would grant more flexible storage conditions to the Pfizer-BioNTech vaccine, which was approved knowing that it needs extremely cold temperatures for storage and distribution.

    Read Also:   WHO suspends tests with Hydroxychloroquine

    Read also: China sets sanctions on British following Western measures

    It (the approval) is anticipated to facilitate the rapid introduction and distribution of the vaccine in the EU by reducing the need for ultra-low-temperature storage conditions throughout the supply chain, the regulator said.

    Last week, an expert committee at the agency recommended new manufacturing lines at a facility in Visp, Switzerland, for Moderna Inc.’s vaccine.

    These changes are intended to increase production capacity and supply of the vaccine to the EU market, the regulator said.

    Read Also:   Violent clashes at mass Paris demonstration over black man's death in custody

    On Thursday, EU leaders failed to resolve a dispute over the distribution of COVID-19 vaccines among member states, but vowed to tighten export controls on the vaccine and vaccine production on EU soil at a time when doses are in short supply and new cases are on the rise.

    Read also: Turkey: Uyghurs protest Chinese foreign minister’s visit

    Richard Ferdinand
    Richard Ferdinand
    Richard Ferdinand is an aspiring Journalist, Explorer, Adventure Loving and Blogger. You can contact him via [email protected]

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Subscribe & Get Latest News

    FOLLOW US

    25,842FansLike
    341FollowersFollow
    641FollowersFollow
    349FollowersFollow
    1,860FollowersFollow
    4,213SubscribersSubscribe